Patent · US Active

Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors

US9663524B2 · kind B2 · utility

14Cited by
53References
27Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 14, 2014
Grant dateMay 30, 2017
Priority date
Expiry dateMar 14, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds of formula I-h:useful as inhibitors of protein kinases, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.